☆ 4.5 Editorial Material

Inflammatory T2 Biomarkers in Severe Asthma Patients: The First Step to Precision Medicine

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma

Laurits Frossing et al.

Summary: This study examined the expression levels of T2 inflammatory markers in patients with severe asthma and their relationship with clinical characteristics and comorbidities. The majority of patients exhibited at least one T2 inflammatory trait, and the coexpression of T2 biomarkers showed high heterogeneity with distinct clinical characteristics.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Allergy

Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry

Eve Denton et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Review Allergy

Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies

Youngsoo Lee et al.

Summary: Severe asthma is a heterogeneous disease characterized by uncontrolled symptoms and lung function decline. The discovery of phenotypes and endotypes has significantly improved our understanding of its pathophysiology.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2021)

添加到收藏夹

Review Allergy